Immunoproteasome modulating therapeutics to transform treatment of autoimmune and inflammatory diseases. PI: Gang Lin, Ph.D. and Carl Nathan, M.D. of Weill Cornell […]

Fracture targeting therapeutic for bone healing PI: Dr. Philip Low, Purdue University Visit site

Hyper-targeted small molecules for reprogramming immune cells to treat disease PI: Dr. Philip Low, Purdue University Visit site

Single molecule protein sequencing PI: Dr. Edward Marcotte, University of Texas at Austin Visit site

Targeted therapeutics platform for Infectious diseases PI: Dr. Philip Low, Purdue University

ASX-100 neutrophil targeting platform to treat significant unmet medical needs PI: Dr. Lola Eniola-Adefeso, University of Michigan Visit site